Safety and Preliminary Effectiveness of NVD-001 for the Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Summary

A prospective multi-centre, randomised, controlled study to evaluate the safety and preliminary effectiveness of NVD-001 for the treatment of low grade degenerative lumbar spondylolisthesis by interbody fusion (L1 - S1).

Timeline

Start

2017-01

Primary completion

2021-01

Completion

2021-06

Outcome

Met primary endpoint

release “The primary endpoint of safety was met. NVD-001 demonstrated a favorable safety profile over a two-year observation” novadip.com ↗

Drugs

Indications